APA (7th ed.) Citation

Schluep, T., Lickliter, J., Hamilton, J., Lewis, D. L., Lai, C., Lau, J. Y., . . . Given, B. D. (2017). Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers. Clinical pharmacology in drug development, 6(4), 350-362. https://doi.org/10.1002/cpdd.318

Chicago Style (17th ed.) Citation

Schluep, Thomas, Jason Lickliter, James Hamilton, David L. Lewis, Ching‐Lung Lai, Johnson YN Lau, Stephen A. Locarnini, Robert G. Gish, and Bruce D. Given. "Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers." Clinical Pharmacology in Drug Development 6, no. 4 (2017): 350-362. https://doi.org/10.1002/cpdd.318.

MLA (9th ed.) Citation

Schluep, Thomas, et al. "Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers." Clinical Pharmacology in Drug Development, vol. 6, no. 4, 2017, pp. 350-362, https://doi.org/10.1002/cpdd.318.